TABLE 1. Incidence rates* and percentages† of invasive lung, bronchial, and tracheal cancers, by demographic and tumor characteristics — United States,§ 2010–2014.
| Demographic characteristic | Total |
Male |
Female |
|||
|---|---|---|---|---|---|---|
| No. | Rate (95% CI) | No. | Rate (95% CI) | No. | Rate (95% CI) | |
|
Total
|
1,070,504
|
61.3 (61.2–61.4)
|
566,713
|
72.7 (72.5–72.9)
|
503,791
|
52.7 (52.5–52.8)
|
|
Age group at diagnosis (yrs)
| ||||||
| <40 |
5,413 |
0.7 (0.7–0.7) |
2,624 |
0.7 (0.7–0.7) |
2,789 |
0.7 (0.7–0.8) |
| 40–49 |
34,419 |
15.6 (15.5–15.8) |
16,262 |
14.9 (14.7–15.2) |
18,157 |
16.4 (16.1–16.6) |
| 50–59 |
163,296 |
74.3 (74.0–74.7) |
87,194 |
81.3 (80.7–81.8) |
76,102 |
67.8 (67.3–68.3) |
| 60–69 |
313,543 |
202.8 (202.1–203.5) |
172,045 |
234.2 (233.1–235.3) |
141,498 |
174.4 (173.5–175.3) |
| 70–79 |
340,129 |
390.0 (388.7–391.3) |
180,917 |
461.9 (459.8–464.0) |
159,212 |
331.6 (330.0–333.3) |
| ≥80 |
213,704 |
374.5 (372.9–376.1) |
107,671 |
502.7 (499.7–505.7) |
106,033 |
298.6 (296.7–300.4) |
|
Race
| ||||||
| White |
920,427 |
62.1 (61.9–62.2) |
483,499 |
72.4 (72.2–72.6) |
436,928 |
54.3 (54.1–54.4) |
| Black |
113,633 |
64.0 (63.6–64.4) |
63,233 |
85.9 (85.2–86.7) |
50,400 |
49.2 (48.7–49.6) |
| American Indian/Alaska Native |
6,000 |
44.7 (43.5–45.9) |
3,111 |
52.2 (50.2–54.2) |
2,889 |
39.0 (37.6–40.6) |
| Asian/Pacific Islander |
25,905 |
35.2 (34.8–35.6) |
14,286 |
45.1 (44.3–45.9) |
11,619 |
27.9 (27.4–28.4) |
|
Ethnicity¶
| ||||||
| Hispanic |
44,500 |
31.9 (31.6–32.2) |
24,297 |
40.8 (40.2–41.3) |
20,203 |
25.5 (25.2–25.9) |
| Non-Hispanic |
1,025,933 |
64.1 (64.0–64.2) |
542,388 |
75.7 (75.5–75.9) |
483,545 |
55.3 (55.1–55.4) |
|
County classification
| ||||||
| Metropolitan |
841,631 |
59.8 (59.7–59.9) |
438,447 |
70.4 (70.1–70.6) |
403,184 |
51.9 (51.8–52.1) |
| Nonmetropolitan |
178,536 |
69.4 (69.0–69.7) |
100,611 |
84.9 (84.4–85.4) |
77,925 |
57.0 (56.6–57.4) |
|
Census region
| ||||||
| Northeast |
208,137 |
62.6 (62.3–62.9) |
104,465 |
72.0 (71.5–72.4) |
103,672 |
56.0 (55.7–56.4) |
| Midwest |
258,247 |
66.5 (66.2–66.7) |
136,591 |
78.6 (78.2–79.0) |
121,656 |
57.4 (57.1–57.7) |
| South |
430,881 |
65.5 (65.3–65.7) |
237,375 |
80.8 (80.4–81.1) |
193,506 |
53.8 (53.6–54.0) |
| West |
173,239 |
47.4 (47.2–47.6) |
88,282 |
53.5 (53.1–53.8) |
84,957 |
42.7 (42.4–43.0) |
|
Tumor characteristic**
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
Total
|
942,919
|
100.0
|
498,902
|
100.0
|
444,017
|
100.0
|
|
Histology
| ||||||
| Non–small cell carcinoma |
764,914 |
81.1 |
408,889 |
81.9 |
356,025 |
80.1 |
| Adenocarcinoma |
448,320 |
47.5 |
215,628 |
43.2 |
232,692 |
52.4 |
| Squamous cell carcinoma |
230,569 |
24.5 |
144,310 |
28.9 |
86,259 |
19.4 |
| Non–small cell carcinoma, NOS |
70,142 |
7.4 |
39,900 |
8.0 |
30,242 |
6.8 |
| Large cell carcinoma |
15,883 |
1.7 |
9,051 |
1.8 |
6,832 |
1.5 |
| Small cell carcinoma |
133,192 |
14.1 |
65,925 |
13.2 |
67,267 |
15.1 |
| Epithelial carcinoma |
23,319 |
2.5 |
13,540 |
2.7 |
9,779 |
2.2 |
| All other histologies |
21,494 |
2.3 |
10,548 |
2.1 |
10,946 |
2.5 |
|
Stage††
| ||||||
| Localized |
189,113 |
20.1 |
89,436 |
17.9 |
99,677 |
22.4 |
| Regional |
227,876 |
24.2 |
120,567 |
24.2 |
107,309 |
24.2 |
| Distant |
495,671 |
52.6 |
272,506 |
54.6 |
223,165 |
50.3 |
| Unknown | 30,259 | 3.2 | 16,393 | 3.3 | 13,866 | 3.1 |
Abbreviations: CI = confidence interval; NOS = not otherwise specified.
* New cases diagnosed per 100,000 persons, age adjusted to the 2000 U.S. standard population.
† New cases diagnosed.
§ Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.)
¶ Ethnicity is not mutually exclusive from race.
** Only includes microscopically confirmed cases; excludes cases identified only through death certificate or autopsy report.
†† Localized: cancer that is confined to the primary site; regional: cancer that has spread directly beyond the primary site or to regional lymph nodes; distant: cancer that has spread to other organs.